Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies

Magnetic Resonance Imaging

Volumn 31, Issue 6, 2013, Pages 947-952

  Costa, Daniel N ^a,b   Bloch, B Nicolas ^a   Yao, David F ^a   Sanda, Martin G ^a   Ngo, Long ^a   Genega, Elizabeth M ^a   Pedrosa, Ivan ^a,b   DeWolf, William C ^a   Rofsky, Neil M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Biopsy; Cancer Diagnosis; Early Detection of Cancer; MRI; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MICROVASCULARIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; SUSCEPTIBILITY WEIGHTED IMAGING; TRANSURETHRAL RESECTION;

AGED; BIOPSY, NEEDLE; BOSTON; FALSE NEGATIVE REACTIONS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PREVALENCE; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 84878647051     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2013.02.007     Document Type: Article

References (37)

1. Durkan G.C., Greene D.R. Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?. BJU Int 1999, 83(1):34-38.
2. Djavan B., et al. Repeat prostate biopsy: who, how and when? A review. Eur Urol 2002, 42(2):93-103.
3. Scattoni V., et al. Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature. Eur Urol 2007, 52(5):1309-1322.
4. Ashley R.A., et al. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008, 53(5):976-981.
5. Lawrentschuk N., et al. 'Prostatic evasive anterior tumours': the role of magnetic resonance imaging. BJU Int 2009, 105(9):1231-1236.
6. Lawrentschuk N., Fleshner N. The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate-specific antigen levels. BJU Int 2009, 103(6):730-733.
7. Park B.K., et al. Prospective evaluation of 3-T MRI performed before initial transrectal ultrasound-guided prostate biopsy in patients with high prostate-specific antigen and no previous biopsy. AJR Am J Roentgenol 2011, 197(5):W876-W881.
8. Labanaris A.P., et al. Prostate cancer detection using an extended prostate biopsy schema in combination with additional targeted cores from suspicious images in conventional and functional endorectal magnetic resonance imaging of the prostate. Prostate Cancer Prostatic Dis 2010, 13(1):65-70.
9. Claus F.G., Hricak H., Hattery R.R. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. Radiographics 2004, 24(Suppl. 1):S167-S180.
10. Degani H., et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution. Nat Med 1997, 3(7):780-782.
11. Koppie T.M., et al. The clinical features of anterior prostate cancers. BJU Int 2006, 98(6):1167-1171.
12. Epstein J.I., Walsh P.C., Brendler C.B. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C). J Urol 1994, 152(5 Pt 2):1721-1729.
13. Chou R., et al. Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2011, 155(11):762-771.
14. Krongrad A., Lai H., Lai S. Variation in prostate cancer survival explained by significant prognostic factors. J Urol 1997, 158(4):1487-1490.
15. Borboroglu P.G., et al. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000, 163(1):158-162.
16. Sella T., et al. Suspected local recurrence after radical prostatectomy: endorectal coil MR imaging. Radiology 2004, 231(2):379-385.
17. Bloch B.N., et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging - initial results. Radiology 2007, 245(1):176-185.
18. Vilanova J.C., et al. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer. AJR Am J Roentgenol 2011, 196(6):W715-W722.
19. Perrotti M., et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. J Urol 1999, 162(4):1314-1317.
20. Kumar V., et al. Transrectal ultrasound-guided biopsy of prostate voxels identified as suspicious of malignancy on three-dimensional (1)H MR spectroscopic imaging in patients with abnormal digital rectal examination or raised prostate specific antigen level of 4-10 ng/ml. NMR Biomed 2007, 20(1):11-20.
21. Pondman K.M., et al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol 2008, 54(3):517-527.
22. Singh A.K., et al. Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int 2008, 101(2):181-185.
23. Beyersdorff D., et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. Radiology 2002, 224(3):701-706.
24. Amsellem-Ouazana D., et al. Negative prostatic biopsies in patients with a high risk of prostate cancer. Is the combination of endorectal MRI and magnetic resonance spectroscopy imaging (MRSI) a useful tool? A preliminary study. Eur Urol 2005, 47(5):582-586.
25. Prando A., et al. Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 2005, 236(3):903-910.
26. Zangos S., et al. MR-compatible assistance system for biopsy in a high-field-strength system: initial results in patients with suspicious prostate lesions. Radiology 2011, 259(3):903-910.
27. Roethke M., et al. MRI-guided prostate biopsy detects clinically significant cancer: analysis of a cohort of 100 patients after previous negative TRUS biopsy. World J Urol 2011, 30(2):213-218.
28. Lee S.H., et al. Magnetic resonance imaging targeted biopsy in men with previously negative prostate biopsy results. J Endourol/Endourol Soc 2012, 26(7):787-791.
29. Kirkham A.P., Emberton M., Allen C. How good is MRI at detecting and characterising cancer within the prostate?. European urology 2006, 50(6):1163-1174. [discussion 1175].
30. Wright J.L., Ellis W.J. Improved prostate cancer detection with anterior apical prostate biopsies. Urol Oncol 2006, 24(6):492-495.
31. Presti J.C., et al. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of nonpalpable and stage T1C carcinoma of the prostate. J Urol 1996, 156(5):1685-1690.
32. McMahon C.J., et al. Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer. Magn Reson Imaging Clin N Am 2009, 17(2):363-383.
33. Weinreb J.C., et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy - results of ACRIN prospective multi- institutional clinicopathologic study. Radiology 2009, 251(1):122-133.
34. Vargas H.A., et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011, 259(3):775-784.
35. Kim C.K., Park B.K., Kim B. Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer. AJR Am J Roentgenol 2010, 194(6):1461-1469.
36. Lim H.K., et al. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection - a multireader study. Radiology 2009, 250(1):145-151.
37. Marks L., Young S., Natarajan S. MRI-ultrasound fusion for guidance of targeted prostate biopsy. Curr Opin Urol 2013, 23(1):43-50.